OVERVIEW

The Point of Care Molecular Diagnostics Market is expected to reach USD 2.68 billion by 2026, growing at a CAGR of 8% during the forecast period. The drivers of this market include the increasing awareness regarding early disease diagnosis for better management of infections, which has a positive impact on the market demand. Several initiatives undertaken by government in underdeveloped and developing regions to create awareness about infectious diseases and prevention is propelling the market growth. Rising incidence of infectious diseases like COVID-19 has stimulated the demand for point of care molecular diagnostic equipment to identify causative agents and further control the spread of disease. Thus, increasing the demand for such products in the market.

TABLE OF CONTENT

1 Global Point of Care Molecular Diagnostics Market

• 1.1 Study Objectives
• 1.2 Market Definition
• 1.3 Study Scope
  • 1.3.1 Markets Covered
  • 1.3.2 Geographic Scope

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Point of Care Molecular Diagnostics Market – Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Point of Care Molecular Diagnostics Market – Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Point of Care Molecular Diagnostics Market – Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis – Top 10 companies

• 6 Global Point of Care Molecular Diagnostics Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Point of Care Molecular Diagnostics Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Point of Care Molecular Diagnostics Market – By Product & Service (Market Size – &

million/billion)

• • 8.1 Assays & Kits
  • 8.2 Instruments/Analyzers
  • 8.3 Services & Software

• 9 Global Point of Care Molecular Diagnostics Market - By Application
  • 9.1 Respiratory diseases
  • 9.2 STDs
  • 9.3 HAIs
  • 9.4 Oncology
  • 9.5 Hepatitis
  • 9.6 Other

• 10 Global Point of Care Molecular Diagnostics Market - By Technology
  • 10.1 RT-PCR
  • 10.2 INAAT
  • 10.3 Others

• 11 Global Point of Care Molecular Diagnostics Market - By End-User
  • 11.1 Physician Offices
  • 11.2 Hospital Emergency Departments & Intensive Care Units
  • 11.3 Research Institutes
  • 11.4 Other

• 12 Global Point of Care Molecular Diagnostics Market – By Geography (Market Size – &

million/billion)

• • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 U.K
    • 12.3.2 Germany
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia-Pacific
    • 12.4.1 China
    • 12.4.2 Japan
    • 12.4.3 India
    • 12.4.4 South Korea
    • 12.4.5 Rest of APAC
  • 12.5 Rest of the World
    • 12.5.1 South America
    • 12.5.2 Middle East
    • 12.5.3 Africa

• 13 Global Point of Care Molecular Diagnostics Market – Entropy
  • 13.1 New product launches
  • 13.2 M&A's, collaborations, JVs and partnerships

• 14 Global Point of Care Molecular Diagnostics Market Company Profile (Key Players)
  • 14.1 Market Share, Company Revenue, Products, M&A, Developments
  • 14.2 Abbott Laboratories
  • 14.3 Danaher Corporation
  • 14.4 Biomérieux Sa
  • 14.5 Meridian Bioscience
  • 14.6 Roche Diagnostics
  • 14.7 DxNA
  • 14.8 Quidel
  • 14.9 Mesa Biotech
  • 14.10 Genepoc
  • 14.11 Atlas Genetics
  • 14.12 Company 11 & more

• 15 Global Point of Care Molecular Diagnostics Market - Appendix
  • 15.1 Sources
  • 15.2 Abbreviations